The DOI matches its Crossref record; 132 of the 133 references it cites were found in a registry or an index.
Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) is a liver manifestation of metabolic syndrome. Overconsumption of high-fat diet (HFD) and increased intake of sugar-sweetened beverages are major risk factors for development of NAFLD. Today the most commonly consumed sugar is high fructose corn syrup. Hepatic lipids may be derived from dietary intake, esterification of plasma free fatty acids (FFA) or hepatic de novo lipogenesis (DNL). A central abnormality in NAFLD is enhanced DNL. Hepatic DNL is increased in individuals with NAFLD, while the contribution of dietary fat and plasma FFA to hepatic lipids is not significantly altered. The importance of DNL in NAFLD is further established in mouse studies with knockout of genes involved in this process. Dietary fructose increases levels of enzymes involved in DNL even more strongly than HFD. Several properties of fructose metabolism make it particularly lipogenic. Fructose is absorbed via portal vein and delivered to the liver in much higher concentrations as compared to other tissues. Fructose increases protein levels of all DNL enzymes during its conversion into triglycerides. Additionally, fructose supports lipogenesis in the setting of insulin resistance as fructose does not require insulin for its metabolism, and it directly stimulates SREBP1c, a major transcriptional regulator of DNL. Fructose also leads to ATP depletion and suppression of mitochondrial fatty acid oxidation, resulting in increased production of reactive oxygen species. Furthermore, fructose promotes ER stress and uric acid formation, additional insulin independent pathways leading to DNL. In summary, fructose metabolism supports DNL more strongly than HFD and hepatic DNL is a central abnormality in NAFLD. Disrupting fructose metabolism in the liver may provide a new therapeutic option for the treatment of NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fructose enhances its own metabolism by upregulating ketohexokinase (KHK), which is elevated in MASLD; diets high in both fat and fructose worsen MASLD, but fructose alone more strongly induces DNL enzymes like ACC1, FASN, and stearoyl-CoA desaturase 1 (SCD1) compared to HFDs [13].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [13]
In the citing paper
“Fructose enhances its own metabolism by upregulating ketohexokinase (KHK), which is elevated in MASLD; diets high in both fat and fructose worsen MASLD, but fructose alone more strongly induces DNL enzymes like ACC1, FASN, and stearoyl-CoA desaturase 1 (SCD1) compared to HFDs [13].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [13]
In the citing paper
“Fructose enhances its own metabolism by upregulating ketohexokinase (KHK), which is elevated in MASLD; diets high in both fat and fructose worsen MASLD, but fructose alone more strongly induces DNL enzymes like ACC1, FASN, and stearoyl-CoA desaturase 1 (SCD1) compared to HFDs [13].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [13]
In the citing paper
“Patients with MASLD often show reduced hepatic ATP [13].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [13]
In the citing paper
“Importantly, DAG buildup, not TG, is linked to hepatic IR via PKC activation.”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Sontrop, J. M., Dixon, S. N., Garg, A. X., Jiménez, I. B., Dohein, O., Huang, S. S., & Clark, W. F. (2013) · American Journal of Nephrology · doi:10.1159/000350377 · Cited by 5,903
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Self-citationTriglyceride accumulation protects against fatty acid-induced lipotoxicity
Listenberger, L. L., Han, X., Lewis, S. E., Cases, S., Farese, R. V., Ory, D. S., & Schaffer, J. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630588100 · Cited by 2,075
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,805
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765
Loomba, R. S., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,732
Insulin Receptor Signaling in Normal and Insulin-Resistant StatesPreprint
Boucher, J., Kleinridders, A., & Kahn, C. R. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009191 · Cited by 1,550
Self-citation
Cited by
Sorted by citations
Items 501–600 of 705
Alireza, H. (2021) · International Journal of Membrane Science and Technology · doi:10.15379/2410-1869.2021.08.02.04 · Cited by 3
Nouveautés dans la stéatose non alcoolique du foie (NAFLD)
Barigou, M., Favre, L., Fraga, M. C., & Artru, F. (2020) · JMIG · doi:10.53738/revmed.2020.16.687.0586 · Cited by 3
Protecting the Liver: Should We Substitute Fruit Juices for Sugar-Sweetened Beverages?
Avignon, A. (2022) · Diabetes Care · doi:10.2337/dci22-0005 · Cited by 3
Fructose promotes more than glucose the adipocytic differentiation of pig mesenchymal stem cells
Campos‐Maldonado, F., González‐Dávalos, L., Piña, E., Anaya‐Loyola, M. A., Shimada, A. S., Varela‐Echavarría, A., & Mora, O. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14429 · Cited by 3
Preclinical models of non-alcoholic steatohepatitis leading to hepatocellular carcinoma
Green, C. D., & Spiegel, S. (2022) · Advances in Biological Regulation · doi:10.1016/j.jbior.2022.100925 · Cited by 3
Mosca, A., Volpe, L. D., Sartorelli, M. R., Comparcola, D., Veraldi, S., Alisi, A., & Maggiore, G. (2023) · Current Pediatric Reviews · doi:10.2174/1573396319666230403121805 · Cited by 3
Shirokova, E. N. (2023) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2023-33-2-79-86 · Cited by 3
Li, Y., Zhang, P., Deng, Y., Yu, C., Chen, X., Liu, X., Yang, Q., Jiang, J., Chen, X., & Xue, H. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.01.009 · Cited by 3
Disordered peptide-based design of intrinsically disordered polymers for biomedical applications
Coskuner‐Weber, O., Çaylı, F. N., & Uversky, V. N. (2025) · International Journal of Polymer Analysis and Characterization · doi:10.1080/1023666x.2025.2458470 · Cited by 3
Liu, Q., & Niu, C.-Y. (2019) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v27.i19.1171 · Cited by 3
Lee, H., Kim, H. J., Chae, H., Yoon, N. E., & Jung, B. H. (2021) · Plants · doi:10.3390/plants10112287 · Cited by 4
Ghosh, S., Khatoon, R., Sarkar, S., & Bandyopadhyay, D. (2023) · Melatonin Research · doi:10.32794/mr112500138 · Cited by 2
Martin, G. G., Landrock, D., McIntosh, A. L., Milligan, S., Landrock, K. K., Kier, A. B., Mackie, J. T., & Schroeder, F. (2020) · Lipids · doi:10.1002/lipd.12238 · Cited by 3
Bukhari, S. N. A., Asif, H., Alamgeer, Asim, M. H., Irfan, H. M., Ejaz, H., Elsherif, M. A., & Junaid, K. (2022) · Metabolites · doi:10.3390/metabo12060481 · Cited by 3
Treatment for Childhood Obesity: Using a Biological Model to Inform Dietary Targets
Ebbeling, C. B., & Ludwig, D. S. (2022) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2022.12.004 · Cited by 3
Park, S., Helsley, R. N., Fadhul, T., Willoughby, J. L. S., Noetzli, L. J., Tu, H.-C., Solheim, M. H., Fujisaka, S., Pan, H., Dreyfuss, J. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.27.525605 · Cited by 3
Self-citationSafraou, Y., Spirgath, K. S., Huang, B., Bayerl, C., Krehl, K., Kühl, A. A., Meyer, T., Shahryari, M., de Moraes, P. A. D., Jordan, J. E. L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.24.678352 · Cited by 3
Taniguchi, A., Watanabe, H., Kimura, K., Hashiuchi, E., Ohashi, N., Sato, H., Sakai, M., Matsumoto, M., Asahara, S., Inoue, H., et al. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151314 · Cited by 2
Porzio, A. D., Barrella, V., Saggese, A., Baccigalupi, L., Cigliano, L., Ricca, E., Iossa, S., & Mazzoli, A. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70063 · Cited by 2
Chen, L., Song, Y., Huang, Y., Hu, J., Meng, Y., Yuan, M., Zheng, G., Wang, X., Zhang, C., & Qiu, Z. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70425 · Cited by 2
Wu, B., Lin, H.-L., Su, H. C., Cheng, P., Ya-Mei, C. H. E. N., Hao, C., & Shen, K. (2025) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.71.321 · Cited by 2
Takahashi, H., Harada, N., Hayamizu, Y., Dungubat, E., Nakazawa, M., Kitakaze, T., Sugimoto, K., INUI, H., YOSHIHARA, E., Takahashi, Y., et al. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00518.2025 · Cited by 2
Experimental models in diabetes research
Dewalkar, L. P. (2026) · Laboratory Animal Research · doi:10.1186/s42826-026-00286-6 · Cited by 2
Insights into the metabolism of lipids in obesity and diabetes
Ayeleso, A. O., Matumba, M. G., Ntambi, J. M., & Mukwevho, E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00017-8 · Cited by 2
Fan, M., Choi, Y., Wedamulla, N. E., Bae, S. M., & Kim, E. (2022) · Food Supplements and Biomaterials for Health · doi:10.52361/fsbh.2022.2.e18 · Cited by 2
Gallbladder - Anatomy, Pathogenesis, and Treatment
Elgeidie, A. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1000409 · Cited by 3
Oshima, T., Takaishi, K., Nishihira, M., Nguyen, S. T., Urakawa, S., Ohno, H., & Fujita, N. (2024) · Physiological Reports · doi:10.14814/phy2.16055 · Cited by 2
Gentzel, M. (2024) · Journal of Bioethical Inquiry · doi:10.1007/s11673-024-10369-5 · Cited by 2
Alam, S., Kawser, M., Ahmed, S. U. N., Alam, M. M., Islam, M. S., & Nasrin, S. (2024) · Clinical Nutrition Open Science · doi:10.1016/j.nutos.2024.10.002 · Cited by 2
Leopold, M., Sanchez, P. B. M., Krizanac, M., Štancl, P., Karlić, R., Prabutzki, P., Parafianczuk, V., Schiller, J., Asimakopoulos, A., Engel, K. M., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2024.159574 · Cited by 2
Zhao, G., Chondon, S., Gray, C., Gentili, S., Stanley, M., & Regnault, T. R. H. (2024) · Current Developments in Nutrition · doi:10.1016/j.cdnut.2024.104510 · Cited by 2
Lemasters, J. J., & Zhong, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15260-3.00026-0 · Cited by 2
Ohshima, K., Hara, E., Takimoto, M., Bai, Y., Hirata, M., Zeng, W., Uomoto, S., Todoroki, M., Kobayashi, M., Kozono, T., et al. (2024) · Biology · doi:10.3390/biology13121027 · Cited by 2
Baumann, A., Freutsmiedl, V., Jelleschitz, J., Staltner, R., Brandt, A., Schachner, D., Dirsch, V. M., & Bergheim, I. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.02.017 · Cited by 2
Jellali, R., Poulain, S., Lereau, M., Gilard, F., Tauran, Y., Kato, S., Danoy, M., Ségard, B.-D., Kido, T., Miyajima, A., et al. (2019) · Process Biochemistry · doi:10.1016/j.procbio.2019.09.034 · Cited by 2
Coelho, I., Pequito, D. C. T., Borghetti, G., Yamaguchi, A. A., de Brito, G. A. P., Yamazaki, R. K., Pôrto, L. C. J., Coimbra, T. M., Fernandes, L. C., & Fernández, R. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1874019 · Cited by 3
Plasma MicroRNA (miRNA)s as Novel Markers of Nonalcoholic Fatty Liver Disease
Akbulut, U. E. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-07389-2_30 · Cited by 2
Role of Endoplasmic Reticulum Stress in Hepatic Injury
Ji, C., Kaplowitz, N., & Han, H. (2017) · Springer eBooks · doi:10.1007/978-3-319-58106-4_10 · Cited by 2
Nadiyah, S., Hastuti, P., & Sunarti, S. (2021) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2021.6045 · Cited by 2
A Short-Term Sucrose Diet Impacts Cell Proliferation of Neural Precursors in the Adult Hypothalamus
Recabal, A., López, S., Salgado, M., Palma, A., Obregón, A. M., Elizondo-Vega, R. J., Sáez, J. C., & García, M. D. L. Á. (2022) · Nutrients · doi:10.3390/nu14132564 · Cited by 2
Effect of various dietary fructose concentrations on the gallstone formation process in mice
del Pozo, R., Mardones, L., Villagrán, M., Muñoz, K., Ramírez, L. T., Mellado, M., & Muñoz-Roa, M. (2023) · Nutrición Hospitalaria · doi:10.20960/nh.04610 · Cited by 2
The mega-importance of de novo lipogenesis in platelet production
Nazy, I., Arnold, D. M., & Steinberg, G. R. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00282-7 · Cited by 2
NAFLD: a multi-faceted morbid spectrum with uncertain diagnosis and complicated management
Renzo, C. D., Vitale, A., D’Amico, F., & Cillo, U. (2021) · Minerva Surgery · doi:10.23736/s2724-5691.21.08729-0 · Cited by 2
Imam, N. U., Idoko, A. S., Osibemhe, M., Lawal, N. O. O., & Zaharaddeen, A. S. (2022) · Journal of applied science and environmental management · doi:10.4314/jasem.v26i5.17 · Cited by 3
Contribution of de novo lipogenesis to the progression of nonalcoholic fatty liver disease
Abdul, M. M. S. (2020) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/81575 · Cited by 2
Fadhul, T., Park, S., Ali, H., Alsiraj, Y., Wali, J. A., Simpson, S. J., & Softic, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.26.625441 · Cited by 2
Self-citationInflammatory Biomarkers in Nutrition
Abreu, S., & Sousa‐Pimenta, M. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81304-8_44-1 · Cited by 1
Gnoni, M. L. (2024) · Norton Healthcare Medical Journal · doi:10.59541/001c.118562 · Cited by 1
Lei, L., Li, J., Liu, Z., Zhang, D., Liu, Z., Wang, Q., Gao, Y., Mo, B., & Li, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-77409-3 · Cited by 1
Discovery of Alkyl Conjugated Diene Diacids as Novel ACLY Inhibitors
Cheng, T., Song, G., Cheng, L., Wang, F., Sun, X., Xie, Z., Zhang, M., Zhang, Y., Li, J., & Nan, F. (2024) · Chinese Journal of Organic Chemistry · doi:10.6023/cjoc202405036 · Cited by 1
SREBP-1c Deficiency Attenuates Fructose-Induced Lipid Droplet Accumulation
Mese-tayfur, S., Isot, I., Cetinkaya, B., Demirel-Yalçıner, T., Özer, N. K., & Sözen, E. (2025) · Clinical and Experimental Health Sciences · doi:10.33808/clinexphealthsci.1603452 · Cited by 1
Lee, S., Min, J. K., Kim, M. J., Yun, S., Seo, M. K., & Lee, J. K. (2025) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.24-0100 · Cited by 1
The gut microbiome and nonalcoholic fatty liver disease: prospects for drug therapy
Teplyuk, D. A., Levina, O. N., Pavlov, C. S., Sorokoletov, S. M., Pashkova, E. Y., As, A., Bolshakov, S. A., & Shutov, E. V. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-230-10-178-187 · Cited by 1
Khodir, S. A., Sweed, E. M., Badr, N. M., Zaki, N. G., Khalil, M. M. I. M., & Adel, M. M. (2025) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2025.2573343 · Cited by 1
Lee, D. Y., Kim, J., Han, M. J., Kim, S. H., Kim, T. H., Eom, D., Song, I., Jeong, D., Yamabe, N., & Kim, K. H. (2025) · Biomedicines · doi:10.3390/biomedicines13122930 · Cited by 1
Zhao, H., Zhang, Z., Chen, X., Tang, C., Song, L., Zhaoxin, L., & Lu, Y. (2026) · Foods · doi:10.3390/foods15030409 · Cited by 1
Boudghane, L. C., Laroussi, M. A., Bouanane, S., Bouabdellah, N., & Ahmed, F. B. (2026) · Acta Alimentaria · doi:10.1556/066.2025.00339 · Cited by 1
Spermidine Supplementation Reduces Genetic Damage in the Liver and Bone Marrow of Rodents
Chacon, J. B., Duarte, M. C., Carvalho, M. O., Ávila, P. F., Menon, I. C., Franco, G. D. M., Paula, B. M. D., & de Oliveira, P. F. (2026) · ACS Omega · doi:10.1021/acsomega.5c11099 · Cited by 1
Treviño, S., Fuentes‐Medel, E., Venegas, B., Muñoz‐Arenas, G., Vázquez‐Roque, R. A., Galindo-Ramírez, F., Avelino-Cruz, J. E., Flores, G., Guevara, J., & Díaz, A. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-026-02501-4 · Cited by 1
Small litter size attenuates adverse hepatic effects induced by a high-sucrose diet
Silva, J. L., de Deus, I. J., de Abreu, A. R. R., Fagundes, M. M. D. A., Breguez, G. S., Carneiro, C. M., Paula-Gomes, S., Costa, D. C., & de Queiroz, K. B. (2026) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2026.110372 · Cited by 1
Khan, I., Meenakshi, S., Abubakar, M., Kumar, N., Gaikwad, V. L., Rai, A., & Murti, K. (2026) · Endocrine · doi:10.1007/s12020-026-04686-5 · Cited by 1
Lugo, R., Solis, A. L. G., Góngora-Chan, P., Jimeno-Figueroa, R. E., Pacheco-Hernández, B., Chim-Aké, R., Vera‐Aviles, M., Williams-Jacquez, D., Chaurand-Lara, M., Valdivieso‐Jiménez, J. A., et al. (2026) · Metabolites · doi:10.3390/metabo16080546 · Cited by 1
Metabolic dysfunction-associated steatotic liver disease in women across the life course
Okigbo, C. C., Springel, E. H., Blaney, H. L., & Sanyal, A. J. (2026) · The Lancet Obstetrics Gynaecology & Women s Health · doi:10.1016/s3050-5038(26)00177-9 · Cited by 1
Animal Models of Obesity Characterized by Non-alcoholic Fatty Liver Disease (NAFLD)
Fernandes, M. R., Figueiredo, P. S., SilvaRezende, K., Freitas, K. D. C., Hiane, P., & Guimarães, R. A. (2017) · InTech eBooks · doi:10.5772/intechopen.72707 · Cited by 1
Agamy, D. F. E., & Ahmed, F. (2020) · Benha Medical Journal · doi:10.21608/bmfj.2020.103529 · Cited by 1
Review on the Role of Fructose in Non-Alcoholic Fatty Liver Diseases
Umaru, I. J., & Emmanuel, O. C. (2022) · International Journal of Scientific and Management Research · doi:10.37502/ijsmr.2022.5212 · Cited by 2
Pan, Y., Liu, B., & Pei, D. (2022) · DNA and Cell Biology · doi:10.1089/dna.2022.0322 · Cited by 1
Salleh, F. H., Goh, Y. M., Lau, S. F., Rani, P. A. M. A., Radzi, R., Mazlan, M., Alashraf, A. R., Goh, S. H., Rahman, S. A., Mohidin, T. B. M., et al. (2022) · Sains Malaysiana · doi:10.17576/jsm-2022-5107-01 · Cited by 1
Wang, Y., Lavier, J., Hua, W., Gong, L., Wei, H., Wang, J., Pellegrin, M., Millet, G. P., & Zhang, Y. (2022) · Life · doi:10.3390/life12101535 · Cited by 1
del Pozo, R. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002044 · Cited by 3
Er, F., Çimen, L., Suveren, C., Yılmaz, C., & Türközkan, N. (2024) · Gazi Medical Journal · doi:10.12996/gmj.2024.4178 · Cited by 1
Вячеславович, Т. Н., Балакина, А. С., Владимировна, М. К., Никитин, Н. С., Aksenov, I. V., Guseva, G. V., & Tutelyan, V. A. (2024) · Journal Biomed · doi:10.33647/2713-0428-20-3e-221-228 · Cited by 1
de Almeida, C. F., Peres, W. A. F., da Silva, P. S., Cardoso, C. S. D. A., de Andrade, M. M., Castro-Alves, J., Quintana, M. D. S. B., Araújo, M. C., Fraga, K. Y. D., Cormack, J. A., et al. (2024) · Metabolism Open · doi:10.1016/j.metop.2024.100334 · Cited by 1
Web of Causation between Dietary Patterns and Childhood Obesity: Applying Hill's Criteria
Șerban, C. L., Șerban, D. M., Butica, S. I., & Lungeanu, D. (2018) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2018-0052 · Cited by 2
When the Beverage Is Sweet, How Does the Liver Feel?
Xi, D., & Kohli, R. (2019) · Current Treatment Options in Pediatrics · doi:10.1007/s40746-019-00177-0 · Cited by 1
Spezifische Therapie – neue Medikamente
Lange, N. F., & Dufour, J. (2022) · Springer eBooks · doi:10.1007/978-3-662-62484-5_21 · Cited by 1
Malattia grassa del fegato: tra fattori ambientali e predisposizione genetica
Mosca, A., & Maggiore, G. (2023) · Medico e Bambino · doi:10.53126/meb42355 · Cited by 1
Therapeutic Approaches for Nonalcoholic Steatohepatitis ( NASH )
Glatthar, R., & Arch, R. H. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc274 · Cited by 1
Zhang, H., Niu, Q., Liang, K., Li, X., Jiang, J., & Bian, C. (2020) · Research Square · doi:10.21203/rs.3.rs-83173/v1 · Cited by 1
Voilquin, L., Liu, T., Jung, Y., Taylor, N. P., Zhao, M., Charville, G. W., Nissen, S. B., Yki‐Järvinen, H., Altman, R. B., & Svensson, K. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.15.504026 · Cited by 1
A liver-specific mitochondrial carrier that controls gluconeogenesis and energy expenditurePreprint
Yook, J.-S., Taxin, Z. H., Yuan, B., Oikawa, S., Auger, C., Mutlu, B., Puigserver, P., Hui, S. T., & Kajimura, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.06.519308 · Cited by 1
Silveira, S. D. S., Moreira, V. M., Peres, M. N. C., Saavedra, L. P. J., Tófolo, L. P., Andrade, F. A., Ribeiro, T. A., Franco, C. C. D. S., Mendes, C. M., Malta, A., et al. (2023) · Preprints.org · doi:10.20944/preprints202307.1077.v1 · Cited by 1
Prevention of Murine Atherosclerosis with Bempedoic Acid
Samsoondar, J. P. (2016) · Scholarship@Western (Western University)
Proteomics of lipid accumulation and DGAT inhibition in HepG2 liver carcinoma cells
Bhatt-Wessel, B. (2017) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17058194
WITHDRAWN: Nonalcoholic steatohepatitis therapies
Dunn, W. (2018) · Liver Research · doi:10.1016/j.livres.2017.12.008
RetractedThe role of folate in non-alcoholic fatty liver disease
Sid, V. (2019) · Mspace (University of Manitoba)
Arnhold, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816388-7.00004-8
Obesity-induced hepatic changes during pregnancy
Grilo, L. F. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Faheem, S. A., Saeed, N. M., El‐Naga, R. N., & Azab, S. S. (2019) · Archives of Pharmaceutical Sciences Ain Shams University · doi:10.21608/aps.2019.17201.1012
Dietary influences on pediatric obesity and metabolic syndrome
Sunil, B., Goss, A. M., & Ashraf, A. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816918-6.00008-1
ESTUDO DA ASSOCIAÇÃO ENTRE O DESFRALDE E O USO DO EU
Moraes, A. V. P. M., Lerner, R., & Amaral, L. Q. (2020) · doi:10.22533/at.ed.1832017069
Lin-you, Z., Hu, N., Wang, N., & Wang, H. (2020) · Natural Product Communications · doi:10.1177/1934578x20946935
NAFLD in Children: Implication for the Future
Corte, C. D., Mosca, A., Pietrobattista, A., Basso, M. S., & Nobili, V. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_11
Fruktosaren kontsumoak eragin ditzakeen osasun arazoak: konponbidea arazo bihurtzen denean
Milton‐Laskibar, I., Besné-Eseverri, I., Carr-Ugarte, H., & Portillo, M. P. (2021) · EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria · doi:10.1387/ekaia.22707
Metadata
- Authors
- Softic, S., Cohen, D. E., & Kahn, C. R.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Kahn, C. Ronald
- Venue
- Digestive Diseases and Sciences
- Published
- 2016-02-08
- Volume
- 61
- Issue
- 5
- Pages
- 1282-1293
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- PMC
- PMC4838515
- OpenAlex
- W2286797029
- Cited by
- 709
- References
- 133
- Citations by year
- 2026: 52 · 2025: 76 · 2024: 88 · 2023: 78 · 2022: 92 · 2021: 79 · 2020: 88 · 2019: 57 · 2018: 44 · 2017: 42 · 2016: 13
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Digestive Diseases and Sciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK031036, R01 DK033201, K12 HD000850, R37 DK048873, R01 DK056626, R01 DK103046)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- non-alcoholic fatty liver disease, dietary fructose, hepatic de novo lipogenesis, high fructose corn syrup, high-fat diet, sugar-sweetened beverages, insulin resistance, SREBP-1c, endoplasmic reticulum stress, uric acid, mitochondrial fatty acid oxidation, reactive oxygen species, hepatic lipid metabolism, metabolic syndrome
- MeSH terms
- Diet, Fructose, Humans, Liver, Lipogenesis, Non-alcoholic Fatty Liver Disease, High Fructose Corn Syrup
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review